IP Library Granted Patent US 10,413,901
Granted Patent B2
US 10,413,901 · App. 15/507,616 · Granted Sep 17, 2019

Methods, devices, and systems for microfluidic stress emulation

Inventors: Marvin J. Slepian (Tucson, AZ); Alberto C. Redaelli (Milan, IT); Marco Rasponi (Milan, IT); Danny Bluestein (Albany, NY)
Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA; THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK; POLITECNICO DI MILANO
B01L3/502746G01N15/1056G01N33/5091A61B5/14546B01L2400/086G01N33/56966G01N33/56972G01N2015/1006G01N2800/224G01N2800/226
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,413,901
App. No.
15/507,616
Granted
Sep 17, 2019
Kind
B2
Abstract

Provided herein is technology relating to microfluidic devices and particularly, but not exclusively, to devices, methods, systems, and kits for imparting stresses on a fluid flowing through a microfluidic device that is designed to mimic a stress profile of a macrofluidic device or pathology.

Claims (14)

1. A method for monitoring platelet activation state in a subject, the method comprising:

a) modeling the shear stress profile of a pathology in a medical device,

wherein the pathology is a cardiovascular pathology,

wherein the medical device is a mechanical circulatory support device,

wherein the modeling comprises one or more of device thrombogenicity emulation, producing a probability density function of the medical device, and determining individual particle trajectories for particles flowing through the medical device;

b) reproducing the shear stress profile of the pathology in the device in a microfluidic device;

c) flowing a sample from the subject through the microfluidic device, wherein the sample comprises platelets separated from a blood sampled obtained from the subject,

wherein the sample has a volume of 1 to 100 nanoliters, 1 to 1000 nanoliters, 1 to 100 microliters, or 1 to 1000 microliters; and

d) testing a platelet activation state of the sample.

2. The method of claim 1 wherein the pathology is a deviation from a normal geometry or flow characteristic.

3. The method of claim 1 wherein the pathology is an arterial narrowing, stenosis, outpouching, anurysm or pseudoaneurysm, dissection, flap, fistula, constriction, thrombus, intinal hyperplasia, or tumor.

4. The method of claim 1 wherein the medical device is a ventricular assist device, stent, total artificial heart, or valve.

5. The method of claim 1 further comprising adjusting the dose of a drug or other therapeutic agent administered to the subject and/or adjusting the dose of an anti-thrombosis drug administered to the subject.

6. The method of claim 1 wherein the sample is acquired from the patient 1 to 10 times a day.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2017
From: REDAELLI, ALBERTO C.; RASPONI, MARCO
To: POLITECNICO DI MILANO
Reel/Frame 043219/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2017
From: SLEPIAN, MARVIN J.
To: ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
Reel/Frame 043093/0821 →
CONFIRMATORY LICENSE Recorded Mar 6, 2017
From: UNIVERSITY OF ARIZONA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041471/0056 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2017
From: BLUESTEIN, DANNY
To: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Reel/Frame 041416/0213 →
Continuity (2)
Provisional Application 62043977 · Aug 29, 2014
Related Publication 20170246632A1 · Aug 31, 2017